SOURCE: Nanobiosym

Nanobiosym

September 17, 2014 12:39 ET

Nanobiosym Global Summit Convenes World Experts in Cambridge to Democratize Healthcare

Summit Will Focus on Early Adopters of Disruptive Technology to Personalize, Mobilize and Decentralize the Next Generation of Healthcare

CAMBRIDGE, MA--(Marketwired - Sep 17, 2014) - Nanobiosym, a leading nanotechnology firm, announced today the agenda for the annual Nanobiosym Global Initiative Summit, which will be held on the Harvard Campus on Saturday September 27th and Sunday September 28th. The conference is being organized in collaboration with Scientific American and will convene key stakeholders in Nanobiosym's global ecosystem including global thought leaders, business leaders, heads of state, leading CEOs, heads of foundations and NGOs, major philanthropists, and select members of the media. The conference is invitation only, but a limited number of spots have been made available to the general public. Applications to attend the conference can be found at http://ngi.nanobiosym.com/registration/. The application deadline is September 21, 2014.

"What Google did for the information industry and cell phones did for telecommunications, we at Nanobiosym will do for healthcare. Since the Industrial Revolution we have been centralizing our social, educational and economic infrastructures. The information age through telecommunications and the Internet has turned that approach upside down. Nanobiophysics brings a similar direct and technology-driven approach to healthcare and our conference organizes the key thought leaders and stakeholders for two days of planning and collaborating on decentralizing, personalizing and mobilizing medicine," said Dr. Anita Goel, M.D., Ph.D., Chairman and CEO, Nanobiosym. http://ngi.nanobiosym.com/.

With the winning of the 2013 XPRIZE, Nanobiosym has emerged from stealth mode to the global stage. The NGI Summit will examine some of the landmark opportunities and challenges that the healthcare system both here in the United States and globally faces and how innovative technologies such as Gene-RADAR® can transform global healthcare infrastructure. With applications in disease diagnosis, pharmaceuticals, and companion diagnostics, Gene-RADAR® is poised to democratize both access and delivery to healthcare.

Speakers at the inaugural NGI Summit include: MIT scientist Bob Langer, Cloud Computing Pioneer Paul Maritz, PepsiCo CSO Mehmood Khan, Emerging Markets Expert Professor Tarun Khanna, Dean of Harvard Business School Nitin Nohria, Chairman of Celgene Cellular Therapeutics Bob Hariri, Novartis Vaccines Research Head Phil Dormitzer, Sanofi CSO Gary Nabel, and X-PRIZE Founder Peter Diamandis. Additional speakers will be added. 

Dr. Goel: "We are building our global partnerships across traditional academic, industrial and geopolitical boundaries and announce new commitments as we mobilize our stakeholders to join us in transforming global healthcare."

About Nanobiosysm
Nanobiosym is developing mobile platforms that quantify molecular fingerprints in real time including nanodiagnostics that will enable novel medicines and therapies to reach patients faster. Our goal is to make medicine less toxic, more precise, more affordable and more effective by personalizing it for each individual. More information is available at www.nanobiosym.com.

Contact Information